GrowingStockReport.com

NASDAQ Gainers Watch List: Cytori Therapeutics, Inc. (NASDAQ:CYTX) and Microvision Inc. (NASDAQ:MVIS) Added to Growing Stock Report's NASDAQ Gainers Watch List

 
Repost This

New York, NY -- (SBWIRE) -- 02/25/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Cytori Therapeutics, Inc. (NASDAQ:CYTX) and Microvision Inc. (NASDAQ:MVIS)

Cytori Therapeutics, Inc. (NASDAQ:CYTX) a company that engages in developing cell therapies based on autologous adipose-derived stem and regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects is up (+2.92%) on 318,688 shares traded after Cytori Therapeutics received a CE Mark in Europe for Intravase. Cytori Therapeutics, Inc. (NASDAQ:CYTX) is currently up (+32.34%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Cytori Therapeutics, Inc. (NASDAQ:CYTX)

Microvision Inc. (NASDAQ:MVIS) a company that engages in the development of miniature laser display and imaging engines based upon its proprietary PicoP display engine technology is up (+9.09%) on 122,761 shares traded as of this writing. Microvision Inc. (NASDAQ:MVIS) is currently up (+65.77%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Microvision Inc. (NASDAQ:MVIS)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com